World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
29453
World Ranking
1604
National Ranking
800

Overview

Jerome H. Kim is affiliated with the Walter Reed Army Institute of Research in the United States. Their primary research field is Medicine, with a focus on Infectious Diseases, Health, Public Health, Environmental and Occupational Health, Virology, and Endocrinology.

The scientist has contributed to research on several core topics, including:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Vibrio bacteria research studies
  • Salmonella and Campylobacter epidemiology
  • Viral gastroenteritis research and epidemiology
  • COVID-19 epidemiological studies

Jerome H. Kim's recent publications include:

  • Looking beyond COVID-19 vaccine phase 3 trials, 2021, Nature Medicine
  • Operation Warp Speed: implications for global vaccine security, 2021, The Lancet Global Health

Other notable publications by the same period focus on vaccine development and urgent healthcare needs related to infectious diseases but involve other primary authors.

The frequent co-authors collaborating with Jerome H. Kim are:

  • Florian Marks
  • Jean-Louis Excler
  • Deok Ryun Kim
  • Birkneh Tilahun Tadesse
  • Merlin L. Robb

Key publication venues where Jerome H. Kim's work appears frequently include:

  • EClinicalMedicine
  • Vaccine
  • Clinical Infectious Diseases
  • npj Vaccines
  • BMJ Global Health

Best Publications

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

    James B. Whitney;Alison L. Hill;Srisowmya Sanisetty;Pablo Penaloza-MacMaster

  • Looking beyond COVID-19 vaccine phase 3 trials.

    Jerome H. Kim;Florian Marks;Florian Marks;Florian Marks;John D. Clemens;John D. Clemens

  • Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

    Victor Valcour;Thep Chalermchai;Napapon Sailasuta;Mary Marovich

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

    Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

    Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

    Amy W. Chung;Musie Ghebremichael;Hannah Robinson;Eric Brown

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • Vaccine development for emerging infectious diseases.

    Jean Louis Excler;Melanie Saville;Seth Berkley;Jerome H. Kim

  • Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Kathryn E. Stephenson;Erica N. Borducchi;Kaitlin Smith

  • Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

    Amy W. Chung;Amy W. Chung;Manu P. Kumar;Kelly B. Arnold;Wen Han Yu;Wen Han Yu

  • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

    David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed

  • Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.

    Jintanat Ananworanich;Alexandra Schuetz;Claire Vandergeeten;Irini Sereti

  • Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

    Merlin L Robb;Leigh A Eller;Hannah Kibuuka;Kathleen Rono

  • Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.

    Donn J. Colby;Lydie Trautmann;Lydie Trautmann;Suteeraporn Pinyakorn;Suteeraporn Pinyakorn;Louise Leyre

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

Frequent Co-Authors

Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Punnee Pitisuttithum
Punnee Pitisuttithum Mahidol University
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science
David C. Montefiori
David C. Montefiori Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Jintanat Ananworanich
Jintanat Ananworanich Moderna Therapeutics (United States)
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Guido Ferrari
Guido Ferrari Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways in clinical and research settings. Many students explore nursing as a critical foundation for patient care linked to immunological health.

Consider starting with programs that are accessible and flexible. For example, the easiest accelerated nursing programs offer a streamlined route for those who already hold a degree in another field but want to fast-track into nursing.

If practical nursing is your goal, understanding which LPN programs are easiest to get into can help you choose a program that fits your needs and enhances your clinical skills efficiently.

Advancing further, nurse practitioners play a vital role in immunology-related specialties. Exploring the easiest NP program options allows you to identify accessible pathways to advanced practice nursing.

For those drawn to mental health and immunology intersections, top online PMHNP programs with best clinical placement rates are valuable to ensure quality clinical experiences and comprehensive training.

Best Scientists Citing Jerome H. Kim

Trending Scientists

Recently Published Articles